✦ LIBER ✦

414A Pharmacological properties and in vitro and in vivo antitumour activity of the potent and selective PI3 kinase inhibitor PI103

✍ Scribed by P. Workman; F. Raynaud; P. Clarke; R. Te Poele; S. Eccles; L. Kelland; F. Di Stefano; K. Ahmadi; P. Parker; M. Waterfield

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

568 POSTER In vitro and in vivo pharmaco

✍ F. Raynaud; S. Eccles; P. Clarke; A. Hayes; F. Di Stefano; Z. Ahmad; S. Guillard 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 60 KB

PI-103, a dual inhibitor of Class IA pho

✍ Park, S; Chapuis, N; Bardet, V; Tamburini, J; Gallay, N; Willems, L; Knight, Z A 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 279 KB

A highly selective, orally bioavailable,

✍ Kenneth R. LaMontagne; Jeannene Butler; Virna B. Borowski; Angel R. Fuentes-Pesq 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 432 KB

In vivo antitumor activity of NVP-AEW541

✍ Carlos Garcı́a-Echeverrı́a; Mark A Pearson; Andreas Marti; Thomas Meyer; Juergen 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 201 KB

1200 ORAL RP5237- a Novel, Selective, an

✍ S. Viswanadha; R. Prasanna; M. Muthuppalaniappan; G. Babu; K. Varanasi; S. Veera 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Characterization of a Novel, Potent and

✍ Crackower, M.A.; Moy, L.Y.; Jia, Y.; Yu, H.; Vincent, S.; Miller, J.R.; Lieber, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 44 KB